Compare Stocks: BTSG, PTCT, VERA, and HRMY

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BTSG BrightSpring Health Services	$70.28 -1.6%	$61.74	$30.64 ▼ $73.75	$14.00B	1.77	2.85 million shs	655,453 shs
HRMY Harmony Biosciences	$33.39 -1.2%	$38.81	$25.90 ▼ $43.49	$1.96B	1	897,146 shs	195,082 shs
PTCT PTC Therapeutics	$63.09 -0.4%	$64.28	$58.80 ▼ $90.87	$5.26B	0.52	1.34 million shs	152,229 shs
VERA Vera Therapeutics	$28.33 -2.4%	$31.24	$26.38 ▼ $56.05	$2.04B	1.07	1.62 million shs	311,815 shs

10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BTSG BrightSpring Health Services	-1.61%	+8.49%	+14.05%	+15.78%	+112.40%
HRMY Harmony Biosciences	-1.23%	+4.10%	-8.72%	-11.33%	+0.78%
PTCT PTC Therapeutics	-2.39%	-3.52%	+5.74%	-11.63%	-15.46%
VERA Vera Therapeutics	-4.72%	-3.65%	+8.40%	-8.19%	-6.56%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BTSG BrightSpring Health Services	$70.28 -1.6%	$61.74	$30.64 ▼ $73.75	$14.00B	1.77	2.85 million shs	655,453 shs
HRMY Harmony Biosciences	$33.39 -1.2%	$38.81	$25.90 ▼ $43.49	$1.96B	1	897,146 shs	195,082 shs
PTCT PTC Therapeutics	$63.09 -0.4%	$64.28	$58.80 ▼ $90.87	$5.26B	0.52	1.34 million shs	152,229 shs
VERA Vera Therapeutics	$28.33 -2.4%	$31.24	$26.38 ▼ $56.05	$2.04B	1.07	1.62 million shs	311,815 shs

10 Stocks Powering The Next AI Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BTSG BrightSpring Health Services	-1.61%	+8.49%	+14.05%	+15.78%	+112.40%
HRMY Harmony Biosciences	-1.23%	+4.10%	-8.72%	-11.33%	+0.78%
PTCT PTC Therapeutics	-2.39%	-3.52%	+5.74%	-11.63%	-15.46%
VERA Vera Therapeutics	-4.72%	-3.65%	+8.40%	-8.19%	-6.56%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BTSG BrightSpring Health Services	3.11	Buy	$77.81	10.75% Upside
HRMY Harmony Biosciences	2.54	Moderate Buy	$48.00	43.05% Upside
PTCT PTC Therapeutics	2.73	Moderate Buy	$99.23	57.91% Upside
VERA Vera Therapeutics	2.80	Moderate Buy	$74.93	164.88% Upside

Current Analyst Ratings Breakdown

Latest BTSG, PTCT, VERA, and HRMY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
11/12/2026	HRMY Harmony Biosciences	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$55.00
11/9/2026	HRMY Harmony Biosciences	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Buy (B-) ➝ Hold (C+)
11/6/2026	VERA Vera Therapeutics	Raymond James Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Set Price Target		$87.00
11/6/2026	VERA Vera Therapeutics	Guggenheim Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$76.00 ➝ $66.00
11/6/2026	VERA Vera Therapeutics	Wedbush Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Neutral	$34.00 ➝ $29.00
11/6/2026	VERA Vera Therapeutics	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$90.00 ➝ $75.00
11/5/2026	BTSG BrightSpring Health Services	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold ➝ Strong-Buy
11/3/2026	BTSG BrightSpring Health Services	Guggenheim Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$81.00 ➝ $84.00
11/2/2026	BTSG BrightSpring Health Services	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C+) ➝ Buy (B)
11/2/2026	BTSG BrightSpring Health Services	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Boost Price Target	Buy	$85.00 ➝ $92.00
11/2/2026	BTSG BrightSpring Health Services	The Goldman Sachs Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Buy	$90.00

(Data available from 11/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BTSG BrightSpring Health Services	$12.91B	1.08	$2.13 per share	33.05	$10.94 per share	6.42
HRMY Harmony Biosciences	$868.45M	2.27	$3.12 per share	10.76	$18.26 per share	1.84
PTCT PTC Therapeutics	$1.16B	4.54	$8.49 per share	7.40	($2.29) per share	-27.44
VERA Vera Therapeutics	N/A	N/A	N/A	N/A	$4.62 per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BTSG BrightSpring Health Services	$190.67M	$1.85	37.96	30.68	0.79	2.69%	18.56%	6.03%	N/A
HRMY Harmony Biosciences	$158.69M	$3.02	11.11	8.56	0.35	18.05%	18.55%	13.24%	N/A
PTCT PTC Therapeutics	$682.64M	-$1.40	N/A	22.60	4.76	-9.17%	N/A	-0.10%	N/A
VERA Vera Therapeutics	-$299.61M	-$5.90	N/A	N/A	N/A	N/A	-90.03%	-70.54%	N/A

Latest BTSG, PTCT, VERA, and HRMY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/5/2026	Q3 2026	VERA Vera Therapeutics	-$1.62	-$1.30	+$0.32	-$1.30	$3.42 million	$10.28 million
11/4/2026	Q3 2026	HRMY Harmony Biosciences	$1.09	$0.81	-$0.28	$0.81	$272.05 million	$268.92 million
10/30/2026	Q3 2026	BTSG BrightSpring Health Services	$0.4728	$0.54	+$0.0672	$0.45	$3.88 billion	$4.21 billion
10/29/2026	Q3 2026	PTCT PTC Therapeutics	$0.1434	-$0.62	-$0.7634	-$0.62	$306.43 million	$357.81 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BTSG BrightSpring Health Services	N/A	N/A	N/A	N/A	N/A
HRMY Harmony Biosciences	N/A	N/A	N/A	N/A	N/A
PTCT PTC Therapeutics	N/A	N/A	N/A	N/A	N/A
VERA Vera Therapeutics	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BTSG BrightSpring Health Services	0.99	1.62	1.22
HRMY Harmony Biosciences	0.12	3.44	3.42
PTCT PTC Therapeutics	N/A	3.27	3.13
VERA Vera Therapeutics	0.23	7.91	10.92

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BTSG BrightSpring Health Services	N/A
HRMY Harmony Biosciences	86.23%
PTCT PTC Therapeutics	N/A
VERA Vera Therapeutics	99.21%

Insider Ownership

Company	Insider Ownership
BTSG BrightSpring Health Services	2.80%
HRMY Harmony Biosciences	11.00%
PTCT PTC Therapeutics	5.30%
VERA Vera Therapeutics	15.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BTSG BrightSpring Health Services	23,500	198.99 million	193.41 million	Optionable
HRMY Harmony Biosciences	293	58.72 million	52.26 million	Optionable
PTCT PTC Therapeutics	991	83.54 million	79.12 million	Optionable
VERA Vera Therapeutics	362	72.06 million	60.61 million	Optionable

BTSG, PTCT, VERA, and HRMY Headlines

Recent News About These Companies

Vera Therapeutics stock: Q3 revenue beats estimates by USD 6.88 million

November 12 at 10:58 PM | ad-hoc-news.deA

HC Wainwright Lifts Earnings Estimates for Vera Therapeutics

November 12 at 1:28 AM | americanbankingnews.com

HC Wainwright Has Strong Forecast for VERA FY2026 Earnings

November 10 at 6:11 AM | marketbeat.com

Vera Therapeutics, Inc. $VERA Shares Bought by Pictet Asset Management Holding SA

November 10 at 5:16 AM | marketbeat.com

Vera Therapeutics, Inc. $VERA Shares Sold by CenterBook Partners LP

November 10 at 3:40 AM | marketbeat.com

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 6, 2026

November 9, 2026 | biospace.comB

Vera Therapeutics, Inc. $VERA Stock Acquired by Candriam S.C.A.

November 9, 2026 | marketbeat.com

Vera Therapeutics (VERA) Receives a Hold from Wedbush

November 8, 2026 | theglobeandmail.com

Vera Therapeutics (NASDAQ:VERA) Upgraded at Wall Street Zen

November 7, 2026 | marketbeat.com

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 6, 2026 | globenewswire.com

Vera Therapeutics Q3 Earnings Call Highlights

November 6, 2026 | marketbeat.com

Vera Therapeutics (VERA) Stock Looks Above Fair Value After A 148% Run

November 6, 2026 | finance.yahoo.com

Vera Therapeutics (NASDAQ:VERA) Stock Gets Price Target Trim from HC Wainwright

November 6, 2026 | marketbeat.com

Vera Therapeutics (VERA) Q3 2026 Earnings Call Transcript

November 6, 2026 | finance.yahoo.com

Vera Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026

November 6, 2026 | marketscreener.comM

Vera Therapeutics Provides Business Update and Reports Third Quarter 2026 Financial Results

November 6, 2026 | finance.yahoo.com

Vera Therapeutics, Inc. (VERA) Q3 2026 Earnings Call Transcript

November 5, 2026 | seekingalpha.com

Vera Therapeutics, Inc. (VERA) Reports Q3 Loss, Tops Revenue Estimates

November 5, 2026 | zacks.com

Vera Therapeutics (NASDAQ:VERA) Releases Quarterly Earnings Results, Beats Expectations By $0.32 EPS

November 5, 2026 | marketbeat.com

Vera Therapeutics (NASDAQ:VERA) Shares Break Above Fifty Day Moving Average - Should You Sell?

November 5, 2026 | marketbeat.com

Vera Therapeutics to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference

November 2, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BTSG, PTCT, VERA, and HRMY Company Descriptions

BrightSpring Health Services NASDAQ:BTSG

$70.28 -1.17 (-1.63%)

As of 01:35 PM Eastern

BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.

Harmony Biosciences NASDAQ:HRMY

$33.38 -0.42 (-1.23%)

As of 01:35 PM Eastern

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.

PTC Therapeutics NASDAQ:PTCT

$63.09 -0.27 (-0.43%)

As of 01:35 PM Eastern

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duchenne muscular dystrophy; Upstaza to treat aromatic l-amino acid decarboxylas (AADC) deficiency, a central nervous system disorder; Tegsedi and Waylivra for the treatment of rare diseases; and Evrysdi to treat spinal muscular atrophy (SMA) in adults and children. Its development pipeline products include Sepiapterin for the treatment of phenylketonuria; PTC518 splicing platform, which is being developed for the treatment of Huntington's disease; and ferroptosis and inflammation platforms, including vatiquinone to treat Friedreich ataxia and utreloxastat for the treatment of amyotrophic lateral sclerosis. The company distributes its products through third-party distributors. It has collaborations with F. Hoffman-La Roche Ltd, Hoffman-La Roche Inc., the SMA Foundation, National Taiwan University, Akcea Therapeutics, Inc., and Shiratori Pharmaceutical Co., Ltd. PTC Therapeutics, Inc. was incorporated in 1998 and is headquartered in South Plainfield, New Jersey.

Vera Therapeutics NASDAQ:VERA

$28.33 -0.71 (-2.44%)

As of 01:35 PM Eastern

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase III clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis that is in Phase II clinical trial. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BTSG, PTCT, VERA, and HRMY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BTSG, PTCT, VERA, and HRMY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BTSG, PTCT, VERA, and HRMY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BTSG, PTCT, VERA, and HRMY Company Descriptions

BrightSpring Health Services NASDAQ:BTSG

Harmony Biosciences NASDAQ:HRMY

PTC Therapeutics NASDAQ:PTCT

Vera Therapeutics NASDAQ:VERA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BTSG, PTCT, VERA, and HRMY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BTSG, PTCT, VERA, and HRMY Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BTSG, PTCT, VERA, and HRMY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BTSG, PTCT, VERA, and HRMY Company Descriptions

BrightSpring Health Services NASDAQ:BTSG

Harmony Biosciences NASDAQ:HRMY

PTC Therapeutics NASDAQ:PTCT

Vera Therapeutics NASDAQ:VERA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools